Comment
doi: 10.1038/nrendo.2010.202.
Cancer: RANKL inhibition—a new weapon against breast cancer?
- PMID: 21197701
- DOI: 10.1038/nrendo.2010.202
Item in Clipboard
Comment
Cancer: RANKL inhibition—a new weapon against breast cancer?
Nat Rev Endocrinol.
2011 Jan.
No abstract available
Comment on
-
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.Nature. 2010 Nov 4;468(7320):98-102. doi: 10.1038/nature09387. Epub 2010 Sep 29. Nature. 2010. PMID: 20881962 Free PMC article.
-
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.Nature. 2010 Nov 4;468(7320):103-7. doi: 10.1038/nature09495. Epub 2010 Sep 29. Nature. 2010. PMID: 20881963
Similar articles
-
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. doi: 10.1186/s13046-018-1001-2. J Exp Clin Cancer Res. 2019. PMID: 30621730 Free PMC article. Review.
-
Can we prevent BRCA1-associated breast cancer by RANKL inhibition?Breast Cancer Res Treat. 2017 Jan;161(1):11-16. doi: 10.1007/s10549-016-4029-z. Epub 2016 Oct 25. Breast Cancer Res Treat. 2017. PMID: 27783278 Review.
-
The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL.Int J Mol Sci. 2020 Oct 14;21(20):7570. doi: 10.3390/ijms21207570. Int J Mol Sci. 2020. PMID: 33066388 Free PMC article. Review.
-
Role of the RANK/RANKL pathway in breast cancer.Maturitas. 2016 Apr;86:10-6. doi: 10.1016/j.maturitas.2016.01.001. Epub 2016 Jan 11. Maturitas. 2016. PMID: 26921922 Review.
-
RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.Breast Cancer Res Treat. 2012 Oct;135(3):771-80. doi: 10.1007/s10549-012-2222-2. Epub 2012 Aug 29. Breast Cancer Res Treat. 2012. PMID: 22926264
Cited by
-
Changes in adiposity over the life course and gene expression in postmenopausal women.Cancer Med. 2022 Jul;11(13):2699-2710. doi: 10.1002/cam4.4649. Epub 2022 Mar 19. Cancer Med. 2022. PMID: 35304837 Free PMC article.
-
Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Oncotarget. 2016 Sep 6;7(36):58684-58695. doi: 10.18632/oncotarget.11017. Oncotarget. 2016. PMID: 27494901 Free PMC article. Review.
-
Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.Cancer Prev Res (Phila). 2018 Dec;11(12):789-796. doi: 10.1158/1940-6207.CAPR-18-0199. Epub 2018 Oct 23. Cancer Prev Res (Phila). 2018. PMID: 30352839 Free PMC article.
-
A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.Cancers (Basel). 2019 Sep 26;11(10):1442. doi: 10.3390/cancers11101442. Cancers (Basel). 2019. PMID: 31561595 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
